CAR-NK cells: A promising cellular immunotherapy for cancer

CAR-NK cells: A promising cellular immunotherapy for cancer

Show other versions (1)

© 2020 The Author(s) Natural Killer (NK) cells and CD8+ cytotoxic T cells are two types of immune cells that can kill target cells through similar cytotoxic mechanisms. With the remarkable success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells for treating haematological malignancies,...

Full description

Bibliographic Details
Main Authors: Xie, Guozhu, Dong, Han, Liang, Yong, Ham, James Dongjoo, Rizwan, Romee, Chen, Jianzhu
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Language:English
Published: Elsevier BV 2022
Online Access:https://hdl.handle.net/1721.1/135407.2

Internet

https://hdl.handle.net/1721.1/135407.2

Similar Items